Enspire
Cleveland, United States · Biotechnology, Health Care, Medical · 10 employees
Enspire DBS Therapy, in partnership with Cleveland Clinic and Boston Scientific, is developing a proprietary deep brain stimulation (DBS) therapy to restore motor function for stroke survivors living with disability. Enspire is currently sponsoring EDEN, a Phase I clinical trial of DBS therapy for stroke recovery.
Funding history
- Series series b — $10.3M — Jan 2026
- Series series b — $17.6M — Aug 2023
Recent signals
- Jan 13, 2026: Raised $10.3M in Series series b
- Aug 01, 2023: Raised $17.6M in Series series b
See plans & pricing → Track Enspire’s funding, hiring, and signals — with verified contacts — on Fundz.